Stocks / Biotech

SRRKBiotech

Scholar Rock Holding Corporation
$51.001d -17.7%5d -7.8%settled close · 2026-09-14
Mkt cap $4.9B (3/25)β 0.6452w $44–62Shares 114.9MInd. Biological Products, (No Diagnostic Substances)Nasdaq since 2018Emp. 289HQ Cambridge, MAscholarrock.com
Who’s talkingIdea Scout · free

Who’s talking about SRRK

No tracked investor commentary on SRRK yet — the corpus grows weekly.
Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →
Earnings

Next report: 12 Nov 2026

Confirmed date · consensus EPS -0.87. Reactions below are the next settled session over the prior close.
The options tape

Notable options days

Sessions in the last 120 where SRRK’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 7 of 120 sessions qualified.

The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
DateCloseRVOL Δ$ flow ($M)Call % LEAPS %+20 sess.
2026-09-14
2026-08-26
2026-08-11
2026-08-06
2026-07-21
2026-07-16
2026-07-08
+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.
Today’s tape on SRRK is in this morning’s Brief. Get The Brief — $20/mo →